gout; state of art

184

Upload: abdallah-allam

Post on 14-Apr-2017

252 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Gout; state of art
Page 2: Gout; state of art

State of Art

Page 3: Gout; state of art
Page 4: Gout; state of art

goutBY:

Abdallah Allam MSc Assistant Lecturer. Department of Physical Medicine,

Rheumatology and Rehabilitation

Faculty of Medicine, Tanta University. Egypt

Page 5: Gout; state of art
Page 6: Gout; state of art

What is the function of uric acid

And purines ?

Page 7: Gout; state of art
Page 8: Gout; state of art

What is the normal ?

Page 9: Gout; state of art

Rees, F. et al. (2014) Optimizing current treatment of goutNat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.32

Page 10: Gout; state of art

Reginato, A. M. et al. (2012) The genetics of hyperuricaemia and gout Nat. Rev. Rheumatol. doi:10.10.38/nrrheum.2012.144

Page 11: Gout; state of art

24 hs urine uric acid excretion

600-800 mg

Page 12: Gout; state of art

Metabolic pathway

Page 13: Gout; state of art
Page 14: Gout; state of art
Page 15: Gout; state of art
Page 16: Gout; state of art

Serum urate level greater than approximately

6.8 mg/dL, the saturation point of urate in

biological fluids, is the underlying cause of gout.

Page 17: Gout; state of art

Why gout doesn’t affect animals?

Page 18: Gout; state of art
Page 19: Gout; state of art

Diet and gout

Page 20: Gout; state of art
Page 21: Gout; state of art
Page 22: Gout; state of art
Page 23: Gout; state of art
Page 24: Gout; state of art

Cherries as one-half cup, or 10 to 12 cherries.==>1- DECREASES SERUM URIC ACID2- Prevents flares3- Reduces pain and inflammation

Page 25: Gout; state of art
Page 26: Gout; state of art

Epidemiology

Page 27: Gout; state of art

BMJ VOLUME 332 3 JUNE 2006

Page 28: Gout; state of art

Etiology

Page 29: Gout; state of art

Over production(5-10%)

Genetic

Acquired

Page 30: Gout; state of art

Genetic - HGPRT deficiency X linked,

*partial Kelly Seeg Miller

*complete Lish Nyhan- G6PD deficiency ( LACTIC )- Over PR1P synthetase

( sensory neural hearing loss).

Acquired- Diet- Obesity - Tumors- Chemotherapy- Alcohol(Lactate, ATP,

Purine guanosine)- Vigorous exercise.- Psoriasis.

Page 31: Gout; state of art

Under excretion(90-95%)

Genetic

Acquired

Page 32: Gout; state of art

Genetic - Down.- PCD.

Acquired *Decreased exc.- RF- KETO ACIDOSIS - LACTIC ACIDOSIS- HYPERTRIGLYCERIDEMIA

*increased Abs.- Dehydration- Starvation - Insulin R- Drugs

Page 33: Gout; state of art

Associated with:Obesity,

Hypertension,

Diabetes (Bell shaped curve),

Sleep Apnea Syndrome.

Hyperlipidaemia.

Page 34: Gout; state of art

Pathogenesis

Page 35: Gout; state of art

Why gout doesn’t always hurt?

Page 36: Gout; state of art
Page 37: Gout; state of art
Page 38: Gout; state of art

Why MSU precipitates in the periphery ?

Page 39: Gout; state of art

· MSU precipitates at the periphery of the body, where

lower body temperatures may reduce the solubility of

MSU.

· Albumin levels decrease, which causes decreased

urate solubility

· Change in ion concentration & decreases of PH

enhance urate deposition

· Trauma promotes urate crystal precipitation

Page 40: Gout; state of art

Mechanism of acute attack

Page 41: Gout; state of art
Page 42: Gout; state of art
Page 43: Gout; state of art

OA and Gout

Page 44: Gout; state of art
Page 45: Gout; state of art
Page 46: Gout; state of art
Page 47: Gout; state of art

Gouty tophus and erosions

Page 48: Gout; state of art
Page 49: Gout; state of art

How does acute attack subside alone?

Page 50: Gout; state of art

Rheumatology 2005;44:1090–1096

Page 51: Gout; state of art
Page 52: Gout; state of art

Heat

Stress steroid release

Page 53: Gout; state of art

C/P

Page 54: Gout; state of art

1 -Early onset.

2 -Classic.

3 -Late onset.

4 -NSAIDs masked.

Page 55: Gout; state of art

1 -Early onset.

Page 56: Gout; state of art
Page 57: Gout; state of art

HPRT

Page 58: Gout; state of art

2 -Classic.

Page 59: Gout; state of art
Page 60: Gout; state of art
Page 61: Gout; state of art
Page 62: Gout; state of art
Page 63: Gout; state of art
Page 64: Gout; state of art

CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 75 • SUPPLEMENT 5 JULY 2008

Page 65: Gout; state of art
Page 66: Gout; state of art

Normal serum uric acid during attack

Page 67: Gout; state of art
Page 68: Gout; state of art
Page 69: Gout; state of art
Page 70: Gout; state of art
Page 71: Gout; state of art
Page 72: Gout; state of art

3 -Late onset.

Page 73: Gout; state of art
Page 74: Gout; state of art

Perioperative goutNSAID MASKED GOUTORGAN TRANSPLANTATION

Page 75: Gout; state of art

Diagnostic work up

Page 76: Gout; state of art

1 -Laboratory investigations

-Plain x-ray

-MSK U/S -DECT

2 -Imaging

3 -Arthrocentesis

Page 77: Gout; state of art

Laboratory investigations

Page 78: Gout; state of art
Page 79: Gout; state of art

24 hs urine collection (not done

during attack)

>800mg / d over producers

<400 mg / d under excretors

Page 80: Gout; state of art

Imaging

Page 81: Gout; state of art

Plain X-ray

Page 82: Gout; state of art

Soft tissue swelling.

Dorsoplantar radiograph

shows mild soft tissue

swelling medial to the first

metarsophalangeal joint .

Page 83: Gout; state of art

Dorsopalmar radiograph

shows soft tissue masses

around the fourth proximal

interphalangeal joint and

radial to the fifth

metacarpophalangeal joint.

The joint spaces are normal.

Page 84: Gout; state of art
Page 85: Gout; state of art
Page 86: Gout; state of art

MSK U/S

Page 87: Gout; state of art
Page 88: Gout; state of art
Page 89: Gout; state of art
Page 90: Gout; state of art
Page 91: Gout; state of art
Page 92: Gout; state of art
Page 93: Gout; state of art
Page 94: Gout; state of art
Page 95: Gout; state of art
Page 96: Gout; state of art
Page 97: Gout; state of art
Page 98: Gout; state of art
Page 99: Gout; state of art
Page 100: Gout; state of art
Page 101: Gout; state of art

DECT

Page 102: Gout; state of art
Page 103: Gout; state of art

Dual-energy CT imaging of tophi in patients with gout

Page 104: Gout; state of art
Page 105: Gout; state of art

Arthrocentesis

Gold standard

Page 106: Gout; state of art

(A) Monosodium urate crystals of gout appear as fine yellow needlelike crystals that are negatively birefringent under compensated polarized light.

(B) In contrast, crystals of calcium pyrophosphate dihydrate (CPPD) crystal deposition disease are rhomboid in shape and weakly positively birefringent under compensated polarized light ABC

Page 107: Gout; state of art
Page 108: Gout; state of art
Page 109: Gout; state of art
Page 110: Gout; state of art

Criteria for Diagnosis

Page 111: Gout; state of art
Page 112: Gout; state of art
Page 113: Gout; state of art
Page 114: Gout; state of art
Page 115: Gout; state of art

DD

Page 116: Gout; state of art
Page 117: Gout; state of art
Page 118: Gout; state of art
Page 119: Gout; state of art
Page 120: Gout; state of art

Procalcitonin ???

Page 121: Gout; state of art
Page 122: Gout; state of art
Page 123: Gout; state of art
Page 124: Gout; state of art
Page 125: Gout; state of art

Medications

Page 126: Gout; state of art

ProbenicidSulfinpyrazone

FebuxostateLosartan

Fenofibrate Vit C

LeflunomideLisinopril

AllopurinolFebuxostate

Pegloticase Rasburicase

Page 127: Gout; state of art
Page 128: Gout; state of art

Colchicine

Page 129: Gout; state of art

Rees, F. et al. (2014) Optimizing current treatment of goutNat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.32

Page 130: Gout; state of art
Page 131: Gout; state of art
Page 132: Gout; state of art
Page 133: Gout; state of art
Page 134: Gout; state of art

Colchicine Creatinine clml/min

Dose >50 0.6 mg twice daily

35-49 0.6 mg once daily

10-34 0.6 every 2 or 3 days

<10 stop

Page 135: Gout; state of art
Page 136: Gout; state of art
Page 137: Gout; state of art
Page 138: Gout; state of art

Avoided in RT TTT by cyclosporine

neuromyotoxicity myopathy (proximal + increased

creatinine + EMG STOP FOR 3 WEEKS CURE

Page 139: Gout; state of art
Page 140: Gout; state of art
Page 141: Gout; state of art

Treat to Target• < 6 mg/dl

• < 5 mg/dl

• < 4 mg/dl ( tophaceous gout)

Page 142: Gout; state of art
Page 143: Gout; state of art

Rees, F. et al. (2014) Optimizing current treatment of gout Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.32

Page 144: Gout; state of art

XOI

Page 145: Gout; state of art
Page 146: Gout; state of art
Page 147: Gout; state of art

Allopurinol GFRml/min

Dose N 300 mg/d

60 200mg/d

30 50-100 mg/d

Page 148: Gout; state of art

ALLOPURINOL HYPERSENSITIVITY SYNDROME

• 5- 10%

• Morbidity and mortality: 20-30%

• MAJOR RISKS:

R I 75%

Diuretic TTT 50%

• ONSET 2-4 WKS

C/P: skin rash , esinophilia, fever, hepatic necrosis, leucocytosis and ↓ RF

TTT: - Steroids - Renal dialysis

Page 149: Gout; state of art
Page 150: Gout; state of art
Page 151: Gout; state of art
Page 152: Gout; state of art
Page 153: Gout; state of art
Page 154: Gout; state of art
Page 155: Gout; state of art
Page 156: Gout; state of art

Pegloticase pegilated uricase

• 8 mg in 250 cc N or half normal saline over 2 hours.

• Every 2 weeks.

• Pre ttt by hydrocortisone iv, acetaminophen 500 -1000 mg

iv & antihistaminics.

• Monitor serum uric acid before each dose ( Auto Abs).

• Colchicine for 3 mos at least.

• Flare of acute attack, Nephrolithiasis, Arthralgia, Nausea,

Dyspepsia, Diarrhea, Rash, Back pain.

CI : G6PD

Page 157: Gout; state of art
Page 158: Gout; state of art

Rasburicase recombinant uricase

• 0.2mg/kg iv over 30 min qd * 5 days

• Every 2 weeks.

• Leukemia , lymphoma , chemotherapy

Page 159: Gout; state of art

ACR 2012 Guidelines

Page 160: Gout; state of art
Page 161: Gout; state of art

(CAN’T LEAP)1-Cyclosporine2. Alcohola. Associated with lactic acid productioni. Reduces renal excretion of urateb. Increases synthesis of urate by accelerating the degradation ofATPc. Beer contains a lot of purine guanosine

3. Nicotinic acid4. Thiazidesa. Interferes with urate excretion at the proximal convoluted tubule5. Lasix6. Ethambutol7. Aspirina. Low dose <2 g/day8. Pyrazinamide

Page 162: Gout; state of art
Page 163: Gout; state of art
Page 164: Gout; state of art
Page 165: Gout; state of art
Page 166: Gout; state of art
Page 167: Gout; state of art
Page 168: Gout; state of art
Page 169: Gout; state of art
Page 170: Gout; state of art
Page 171: Gout; state of art
Page 172: Gout; state of art
Page 173: Gout; state of art

Rees, F. et al. (2014) Optimizing current treatment of goutNat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.32

Page 174: Gout; state of art
Page 175: Gout; state of art
Page 176: Gout; state of art
Page 177: Gout; state of art
Page 178: Gout; state of art
Page 179: Gout; state of art
Page 180: Gout; state of art
Page 181: Gout; state of art
Page 182: Gout; state of art
Page 183: Gout; state of art
Page 184: Gout; state of art

Thank you